- Fund Type: Unit Trust
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: Global
AXA Framlington Biotech Fund
+ Add to WatchlistFRABIOA:LN
83.31 GBp 0.000.00%As of 00:59:30 ET on 06/14/2013.
Snapshot for AXA Framlington Biotech Fund (FRABIOA)
| Year To Date: | +31.37% | 3-Month: | +6.72% | 3-Year: | +22.51% | 52-Week Range: | 60.41 - 90.26 |
|---|---|---|---|---|---|---|---|
| 1-Month: | -5.96% | 1-Year: | +36.93% | 5-Year: | +18.96% | Beta vs NBI: | 0.80 |
Fund Profile & Information for FRABIOA
AXA Framlington Biotech Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to provide long-term capital appreciation The Fund will invest principally in equity securities of companies in the biotechnology, genomic and medical research industries worldwide.
| Inception Date: | 11-26-2001 | Telephone: | 44-207-374-4100 |
|---|---|---|---|
| Managers: | LINDEN THOMSON / GEMMA GAME | ||
| Web Site: | www.axaframlington.com | ||
Fundamentals for FRABIOA
| NAV | (on 2013-06-19) 83.14 |
|---|---|
| Assets (M) | (on 2013-03-28) 127.99 |
| Fund Leveraged | N |
| Minimum Investment | 1,000.00 |
| Minimum Subsequent Investment | 100.00 |
Dividends for FRABIOA
| Dividend Type | Omitted |
|---|---|
| Dividend Frequency | Semi-Anl |
| Last Dividend Net | - |
| Dividend Yield (ttm) | - |
Fees & Expenses for FRABIOA
| Front Load | 5.50 |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 1.75 |
| Redemption Fee | 0.00 |
| 12b1 Fee | - |
| Expense Ratio | 1.95 |
Top Fund Holdings for FRABIOA
Filing Date: 02/28/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Gilead Sciences Inc | 376,414 | 10,627,259 | 9.364% |
| Celgene Corp | 137,913 | 9,171,809 | 8.082% |
| Amgen Inc | 139,201 | 8,340,242 | 7.349% |
| Regeneron Pharmaceuticals Inc | 73,116 | 7,931,751 | 6.989% |
| Alexion Pharmaceuticals Inc | 113,472 | 6,459,573 | 5.692% |
| Vertex Pharmaceuticals Inc | 150,158 | 4,642,677 | 4.091% |
| Biogen Idec Inc | 41,584 | 4,545,595 | 4.005% |
| Onyx Pharmaceuticals Inc | 75,395 | 3,839,853 | 3.383% |
| Illumina Inc | 99,308 | 3,204,476 | 2.824% |
| Incyte Corp Ltd | 203,599 | 2,896,209 | 2.552% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page